Stockscreener 앱 받기
100.69
0.29%
0.295
시간 외 거래:
100.50
-0.195
-0.19%
전일 마감가:
$100.40
열려 있는:
$97.31
하루 거래량:
551.28K
Relative Volume:
0.65
시가총액:
$3.45B
수익:
$605.49M
순이익/손실:
$190.29M
주가수익비율:
20.73
EPS:
4.8571
순현금흐름:
$133.59M
1주 성능:
-1.47%
1개월 성능:
-31.50%
6개월 성능:
-13.25%
1년 성능:
+37.73%
1일 변동 폭
$96.01
$101.73
1주일 범위
$93.08
$102.62
52주 변동 폭
$62.23
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
100.69 | 3.45B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 업그레이드 | Needham | Hold → Buy |
| 2025-10-13 | 개시 | Jefferies | Buy |
| 2025-09-16 | 개시 | Evercore ISI | Outperform |
| 2025-09-04 | 개시 | Stifel | Hold |
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | NDAQ:TMDX | Press Release - Stockhouse
TransMedics’ clinical pipeline to drive next phase of growth - S&P Global
Investors who lost money on TransMedics Group, Inc.(TMDX) should - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Zevenbergen Capital Investments LLC Boosts Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
TransMedics (TMDX) down 20.3% since last earnings report: Can it rebound? - MSN
TransMedics Group (TMDX) price target increased by 10.46% to 164.50 - MSN
[SCHEDULE 13G/A] TransMedics Group, Inc. Amended Passive Investment Disclosure - Stock Titan
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform Ambitions - Yahoo Finance
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Shares Down 4.5%Here's What Happened - MarketBeat
Consider Keeping TransMedics Shares in Your Portfolio at This Time - Bitget
Reasons to Retain TransMedics Stock in Your Portfolio for Now - finance.yahoo.com
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (STU:TMDX) NonCurrent Deferred Revenue : €0.0 Mil (As of Dec. 2025) - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push - MarketBeat
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect | NDAQ:TMDX | Press Release - Stockhouse
A Look At TransMedics Group (TMDX) Valuation After Share Pullback And Insider Selling Reports - simplywall.st
Stocks showing improved relative strength: TransMedics Group - MSN
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), HOYA (OtherHOCPF) and TransMedics Group (TMDX) - The Globe and Mail
Stifel Initiates Coverage of TransMedics Group (TMDX) with Hold Recommendation - MSN
TransMedics (TMDX) Faces Downward Pressure Amid Insider Selling and Market Concerns - GuruFocus
TransMedics Extends Decline as Selling Pressure Builds - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics Group (NASDAQ:TMDX) Trading Down 7.4%What's Next? - MarketBeat
Why TransMedics Group Stock Is Sliding Today - TipRanks
Morgan Stanley Maintains TransMedics Group (TMDX) Equal-Weight Recommendation - MSN
TransMedics Group Q4 2025 earnings preview - MSN
17,165 Shares in TransMedics Group, Inc. $TMDX Acquired by Kensington Investment Counsel LLC - MarketBeat
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group, Inc. $TMDX Shares Bought by Fred Alger Management LLC - MarketBeat
Cowen Maintains Buy on TransMedics Group, Inc. (TMDX) March 2026 - Meyka
Aug Mood: Can TransMedics Group Inc expand its profit margins2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
TransMedics Group, Inc. Trade Ideas — LS:A2PH5P - TradingView
Lovell, TransMedics director, sells $178k in TMDX stock By Investing.com - Investing.com Nigeria
TransMedics Group stock (ISIN: US89366D3075): FDA liver tailwind, kidney upside and European push re - AD HOC NEWS
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled By Investing.com - Investing.com South Africa
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled - Investing.com
TMDX: Pursuing deeper U.S. integration, expanding in Europe, and advancing major clinical trials - TradingView
TD Cowen reiterates TransMedics stock Buy rating on liver approval - Investing.com
TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven (NASDAQ:TMDX) - Seeking Alpha
Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out - ACCESS Newswire
Analysts raise TransMedics Group, Inc. (TMDX) price targets after Q4 results - MSN
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Transmedics Group Inc 주식 (TMDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Mar 04 '26 |
Option Exercise |
14.20 |
3,571 |
50,708 |
15,705 |
| Weill David | Director |
Mar 04 '26 |
Sale |
146.82 |
3,571 |
524,294 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Option Exercise |
71.17 |
7,236 |
515,001 |
20,601 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Sale |
147.21 |
7,236 |
1,065,212 |
14,689 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 02 '26 |
Sale |
139.12 |
375 |
52,170 |
14,689 |
| Ranganath Anil P. | See remarks |
Mar 02 '26 |
Sale |
139.12 |
864 |
120,200 |
13,091 |
| Corcoran Nicholas | See remarks |
Mar 02 '26 |
Sale |
139.12 |
2,966 |
412,630 |
29,831 |
0.15%
자본화:
|
볼륨(24시간):